What Emtricitabine \/ Tenofovir disoproxil Mylan is and what it is used for<\/h2>\n\n\n\n
Emtricitabine \/ Tenofovir disoproxil Mylan contains two active substances, <\/strong>emtricitabine<\/em> and tenofovir disoproxil<\/em>. Both of these active substances are antiretroviral drugs used to treat HIV – infection. Emtricitabine is a nucleoside reverse transcriptase inhibitor<\/em> and tenofovir is a nucleotide reverse transcriptase inhibitor. <\/em>However, both are commonly called NRTIs and act by affecting the normal function of an enzyme (reverse transcriptase) that the virus needs for its reproduction (propagation).<\/p>\n\n\n\n
Emtricitabine \/ Tenofovir disoproxil Mylan is a treatment for human immunodeficiency virus 1 infection ( HIV \u20111)<\/strong> in adults.<\/li>
It is also used to treat HIV in adolescents aged 12 to 18 years who weigh at least 35 kg<\/strong> and who have already been treated with other HIV medicines that are no longer effective or that have caused side effects.
Emtricitabine \/ Tenofovir disoproxil Mylan should always be taken in combination with other HIV medicines.<\/li>
Emtricitabine \/ Tenofovir disoproxil Mylan may be used instead of separate administration of emtricitabine and tenofovir disoproxil at the same dose.<\/li><\/ul><\/li><\/ul>\n\n\n\n
People who are HIV -positive can still transmit HIV -smitten<\/strong> when taking this medicine, even though the risk is reduced with effective antiretroviral treatment. Discuss the necessary steps to avoid infecting others with your doctor. <\/p>\n\n\n\n
This medicine does not cure HIV – infection<\/strong>. While taking emtricitabine\/tenofovir disoproxil Mylan may still develop infections you or other illnesses associated with HIV – infection.<\/p>\n\n\n\n
Emtricitabine\/tenofovir<\/strong> disoproxil Mylan is also used to reduce the risk of being infected with HIV -1 in adults and young people 12 years and up to less than 18 years who weigh at least 35 kg, when used daily with safe sex: See Section 2 for a list of precautions that can be taken against HIV – infection.<\/li><\/ul>\n\n\n\n
What you need to know before you take Emtricitabine \/ Tenofovir disoproxil Mylan<\/h2>\n\n\n\n
Do not take Emtricitabine \/ Tenofovir disoproxil Mylan for HIV or to reduce the risk of HIV infection if you are allergic <\/h2>\n\n\n\n
against emtricitabine, tenofovir, tenofovir disoproxil, or any of the other ingredients of this medicine (listed in section 6). <\/p>\n\n\n\n
\u2192 If this applies to you, tell your doctor immediately.<\/strong> <\/p>\n\n\n\n
Before you take Emtricitabine \/ Tenofovir disoproxil Mylan to reduce your risk of getting HIV:<\/strong> <\/p>\n\n\n\n
This medicine can only help reduce the risk of getting HIV before<\/strong> you become infected.<\/p>\n\n\n\n
To reduce the risk of getting HIV<\/strong>, you must be HIV- negative before you start taking this medicine. You must be tested to ensure that you do not already have HIV – infection. Do not take this medicine to reduce your risk of infection unless you have been confirmed to be HIV- negative. People with HIV must take this medicine in combination with other medicines.<\/li>
Many HIV tests do not show a recent infection. If you get a flu-like illness, it could mean that you have recently been infected with HIV. These may be signs of HIV infection:
fatigue<\/li>
fever<\/li>
joint or muscle pain<\/li>
headache<\/li>
vomiting or diarrhea<\/li>
rash<\/li>
night sweats<\/li>
enlarged lymph nodes in the throat or groin. \u00e0 Tell your doctor about any possible flu-like symptoms<\/strong> – either during the month before starting treatment with this medicine or at any time while you are taking this medicine.<\/li><\/ul><\/li><\/ul>\n\n\n\n
Warnings and cautions<\/h2>\n\n\n\n
While you are taking Emtricitabine \/ Tenofovir disoproxil Mylan to reduce your risk of getting HIV:<\/strong><\/p>\n\n\n\n
Take this medicine every day to reduce the risk, not just when you think you have been exposed to the risk of getting HIV – infection. Do not miss any dose of Emtricitabine \/ Tenofovir disoproxil Mylan or stop taking it. If you miss the dose you may be more likely that you suffer from HIV – infection increase.<\/li>
Get tested regularly for HIV.<\/li>
If you think you have been infected with HIV, tell your doctor immediately. Your doctor may want to perform several tests to make sure you are still HIV- negative.<\/li>
Taking Emtricitabine \/ Tenofovir disoproxil Mylan alone may not prevent you from getting HIV.
Always exercise safe sex. Use a condom to reduce contact with semen, vaginal fluids, or blood.<\/li>
Do not share personal items where there may be blood or body fluids, e.g. toothbrushes and razor blades.<\/li>
Do not share or reuse needles or other injection or drug equipment.<\/li>
Get tested for other sexually transmitted infections such as syphilis and gonorrhea. These infections make it easier for you to get infected with HIV.<\/li><\/ul><\/li><\/ul>\n\n\n\n
Talk to your doctor if you have more questions about how to prevent getting HIV or transmitting HIV to other people. <\/p>\n\n\n\n
While taking Emtricitabine \/ Tenofovir disoproxil Mylan for treatment of HIV or to reduce the risk of getting HIV:<\/strong><\/p>\n\n\n\n
Emtricitabine\/tenofovir<\/strong> disoproxil may affect your kidneys. Before and during treatment, your doctor may prescribe some blood tests to measure your kidney function. Tell your doctor if you have a history of kidney disease or if tests have shown that you have kidney problems. Emtricitabine \/ Tenofovir disoproxil Mylan should not be used in adolescents with pre-existing kidney problems. If you have kidney problems, your doctor may advise you to stop taking emtricitabine\/tenofovir disoproxil or, if you already have HIV, to take the tablets less often. Emtricitabine\/tenofovir disoproxil is not recommended if you have severe kidney disease or if you are on dialysis. Skeletal problems (which sometimes lead to fractures ) can also occur due to damage to the renal tubules (see section 4, Possible side effects ).<\/li>
Tell your doctor if you already have or have had liver disease, including hepatitis. HIV patients with liver disease (including chronic hepatitis B or C) treated with antiretroviral agents are at increased risk for severe and potentially fatal liver complications. If you have hepatitis B or C, your doctor will carefully choose the best treatment for you.<\/li>
Find out about your hepatitis B virus status (HBV status) before you start taking Emtricitabine \/ Tenofovir disoproxil Mylan. If you have HBV, there is a serious risk of liver problems when you stop taking emtricitabine\/tenofovir disoproxil, whether you have HIV or not. It is important not to stop taking emtricitabine\/tenofovir disoproxil without talking to your doctor, see section 3, \u201c Do not stop taking Emtricitabine \/ Tenofovir ET disoproxil Mylan \u201d.<\/li>
Talk to your doctor if you are over 65 years old. Emtricitabine\/tenofovir disoproxil has not been studied in patients over 65 years of age.<\/li>
Talk to your doctor if you have lactose intolerance<\/strong> (see \u201cEmtricitabine \/ Tenofovir disoproxil Mylan contains lactose\u201d later in this section).<\/li><\/ul>\n\n\n\n
Children and young people<\/h2>\n\n\n\n
Emtricitabine \/ Tenofovir disoproxil Mylan should not be used in children under 12 years of age.<\/p>\n\n\n\n
Other medicines and Emtricitabine \/ Tenofovir disoproxil Mylan<\/h2>\n\n\n\n
Do not take Emtricitabine \/ Tenofovir disoproxil Mylan<\/strong> if you are already taking other medicines that contain the components of this medicine (which are emtricitabine and tenofovir disoproxil), or other antiviral medicines that contain tenofoviralafenamide, lamivudine<\/a>, or adefovir dipivoxil. <\/p>\n\n\n\n